Clinical implementation of MR‐guided vaginal cylinder brachytherapy
dc.contributor.author | Owrangi, Amir M. | |
dc.contributor.author | Jolly, Shruti | |
dc.contributor.author | Balter, James M. | |
dc.contributor.author | Cao, Yue | |
dc.contributor.author | Maturen, Katherine E. | |
dc.contributor.author | Young, Lisa | |
dc.contributor.author | Zhu, Tong | |
dc.contributor.author | Prisciandaro, Joann I. | |
dc.date.accessioned | 2017-01-10T19:05:19Z | |
dc.date.available | 2017-01-10T19:05:19Z | |
dc.date.issued | 2015-11 | |
dc.identifier.citation | Owrangi, Amir M.; Jolly, Shruti; Balter, James M.; Cao, Yue; Maturen, Katherine E.; Young, Lisa; Zhu, Tong; Prisciandaro, Joann I. (2015). "Clinical implementation of MR‐guided vaginal cylinder brachytherapy." Journal of Applied Clinical Medical Physics 16(6): 490-500. | |
dc.identifier.issn | 1526-9914 | |
dc.identifier.issn | 1526-9914 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/135295 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | ICRU | |
dc.subject.other | MRI | |
dc.subject.other | applicator reconstruction | |
dc.subject.other | brachytherapy | |
dc.title | Clinical implementation of MR‐guided vaginal cylinder brachytherapy | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/135295/1/acm20490.pdf | |
dc.identifier.doi | 10.1120/jacmp.v16i6.5460 | |
dc.identifier.source | Journal of Applied Clinical Medical Physics | |
dc.identifier.citedreference | Hoskin PJ, Vidler K. Vaginal vault brachytherapy: the effect of varying bladder volumes on normal tissue dosimetry. Br J Radiol. 2000; 73 ( 872 ): 864 – 66. | |
dc.identifier.citedreference | Nesvacil N, Potter R, Sturdza A, Hegazy N, Federico M, Kirisits C. Adaptive image guided brachytherapy for cervical cancer: a combined MRI‐/CT‐planning technique with MRI only at first fraction. Radiother Oncol. 2013; 107 ( 1 ): 75 – 81. | |
dc.identifier.citedreference | Krishnatry R, Patel FD, Singh P, Sharma SC, Oinam AS, Shukla AK. CT or MRI for image‐based brachytherapy in cervical cancer. Jpn J Clin Oncol. 2012; 42 ( 4 ): 309 – 13. | |
dc.identifier.citedreference | Tan LT. Implementation of image‐guided brachytherapy for cervix cancer in the UK: progress update. Clin Oncol. 2011; 23 ( 10 ): 681 – 84. | |
dc.identifier.citedreference | Pavamani S, D’Souza DP, Portelance L, et al. Image‐guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey. Brachytherapy. 2011; 10 ( 5 ): 345 – 51. | |
dc.identifier.citedreference | Kim H, Beriwal S, Houser C, Huq MS. Dosimetric analysis of 3D image‐guided HDR brachytherapy planning for the treatment of cervical cancer: is point A‐based dose prescription still valid in image‐guided brachytherapy? Med Dosim. 2011; 36 ( 2 ): 166 – 70. | |
dc.identifier.citedreference | Tan LT, Coles CE, Hart C, Tait E. Clinical impact of computed tomography‐based image‐guided brachytherapy for cervix cancer using the tandem‐ring applicator — the Addenbrooke’s experience. Clin Oncol. 2009; 21 ( 3 ): 175 – 82. | |
dc.identifier.citedreference | Dimopoulos JC, Potter R, Lang S, et al. Dose‐effect relationship for local control of cervical cancer by magnetic resonance image‐guided brachytherapy. Radiother Oncol. 2009; 93 ( 2 ): 311 – 15. | |
dc.identifier.citedreference | Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Potter R. Computed tomography versus magnetic resonance imaging‐based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007; 68 ( 2 ): 491 – 98. | |
dc.identifier.citedreference | Nag S, Cardenes H, Chang S, et al. Proposed guidelines for image‐based intracavitary brachytherapy for cervical carcinoma: report from Image‐Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys. 2004; 60 ( 4 ): 1160 – 72. | |
dc.identifier.citedreference | Zhou J, Prisciandaro J, Lee C, Schipper M, Eisbruch A, Jolly S. Single or multi‐channel vaginal cuff high‐dose‐rate brachytherapy: Is replanning necessary prior to each fraction? Pract Radiat Oncol. 2014; 4 ( 1 ): 20 – 26. | |
dc.identifier.citedreference | Holloway CL, Macklin EA, Cormack RA, Viswanathan AN. Should the organs at risk be contoured in vaginal cuff brachytherapy? Brachytherapy. 2011; 10 ( 4 ): 313 – 17. | |
dc.identifier.citedreference | Stewart AJ, Cormack RA, Lee H, et al. Prospective clinical trial of bladder filling and three‐dimensional dosimetry in high‐dose‐rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys. 2008; 72 ( 3 ): 843 – 48. | |
dc.identifier.citedreference | Cameron AL, Cornes P, Al‐Booz H. Brachytherapy in endometrial cancer: quantification of air gaps around a vaginal cylinder. Brachytherapy. 2008; 7 ( 4 ): 355 – 58. | |
dc.identifier.citedreference | Kim H, Rajagopalan MS, Houser C, Beriwal S. Dosimetric comparison of multichannel with one single‐channel vaginal cylinder for vaginal cancer treatments with high‐dose‐rate brachytherapy. Brachytherapy. 2014; 13 ( 3 ): 263 – 67. | |
dc.identifier.citedreference | Chapman CH, Prisciandaro J, Maturen K, et al. MRI‐based evaluation of coverage of the vaginal cuff in endometrial brachytherapy: are we missing the target? Brachytherapy. 2015; 14: S17. | |
dc.identifier.citedreference | Cunha JAM, Mellis K, Sethi R, et al. Evaluation of PC‐ISO for customized, 3D printed, gynecologic 192 Ir HDR brachytherapy applicators. J Appl Clin Med Phys. 2015; 16 ( 1 ): 246 – 53. | |
dc.identifier.citedreference | Wiebe E, Easton H, Thomas G, Barbera L, D’Alimonte L, Ravi A. Customized vaginal vault brachytherapy with computed tomography imaging‐derived applicator prototyping. Brachytherapy. 2015; 14 ( 3 ): 380 – 84. | |
dc.identifier.citedreference | Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y. Magnetic resonance imaging (MRI) markers for MRI‐guided high‐dose‐rate brachytherapy: novel marker‐flange for cervical cancer and marker catheters for prostate cancer. Int J Radiat Oncol Biol Phys. 2013; 86 ( 2 ): 387 – 93. | |
dc.identifier.citedreference | Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image‐based dose planning of brachytherapy for cervical cancer. Radiother Oncol. 2009; 91 ( 2 ): 187 – 93. | |
dc.identifier.citedreference | Iftimia I, Cirino ET, Mower HW, McKee AB. Treatment planning methodology for the Miami Multichannel Applicator following the American Brachytherapy Society recently published guidelines: the Lahey Clinic experience. J Appl Clin Med Phys. 2013; 14 ( 1 ): 4098. | |
dc.identifier.citedreference | Winkler ML and Hricak H. Pelvis imaging with MR: technique for improvement. Radiology. 1986; 158 ( 3 ): 848 – 49. | |
dc.identifier.citedreference | Kier R, Wain S, Troiano R. Fast spin‐echo MR images of the pelvis obtained with a phased‐array coil: value in localizing and staging prostatic carcinoma. AJR. 1993; 161 ( 3 ): 601 – 06. | |
dc.identifier.citedreference | Eli Lilly and Company. Indication and important safety information on glucagon. Indianapolis, IN: Eli Lilly and Company; 2014. Available from: http://www.lillyglucagon.com/important‐safety‐information Accessed May 2014. | |
dc.identifier.citedreference | Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA. 2010; 60 ( 5 ): 277 – 300. | |
dc.identifier.citedreference | Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high‐intermediate risk (PORTEC‐2): an open‐label, non‐inferiority, randomised trial. Lancet. 2010; 375 ( 9717 ): 816 – 23. | |
dc.identifier.citedreference | Nout RA, Putter H, Jurgenliemk‐Schulz IM, et al. Five‐year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC‐2) trial and comparison with norm data. Eur J Cancer. 2012; 48 ( 11 ): 1638 – 48. | |
dc.identifier.citedreference | Nout RA, Putter H, Jurgenliemk‐Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC‐2 trial. J Clin Oncol. 2009; 27 ( 21 ): 3547 – 56. | |
dc.identifier.citedreference | Patel MK, Cote ML, Ali‐Fehmi R, Buekers T, Munkarah AR, Elshaikh MA. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end‐results study. Int J Radiat Oncol Biol Phys. 2012; 83 ( 1 ): 178 – 84. | |
dc.identifier.citedreference | International Commission on Radiological Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. Report 38. Bethesda, MD: ICRU; 1985. | |
dc.identifier.citedreference | Viswanathan AN and Erickson BA. Three‐dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2010; 76 ( 1 ): 104 – 09. | |
dc.identifier.citedreference | Haie‐Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC‐ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005; 74 ( 3 ): 235 – 45. | |
dc.identifier.citedreference | Potter R, Haie‐Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image‐based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image‐based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006; 78 ( 1 ): 67 – 77. | |
dc.identifier.citedreference | Hellebust TP, Kirisits C, Berger D, et al. Recommendations from Gynaecological (GYN) GEC‐ESTRO Working Group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image‐based treatment planning of cervix cancer brachytherapy. Radiother Oncol. 2010; 96 ( 2 ): 153 – 60. | |
dc.identifier.citedreference | Dimopoulos JCA, Petrow P, Tanderup K, et al. Recommendations from Gynaecological (GYN) GEC‐ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012; 103 ( 1 ): 113 – 22. | |
dc.identifier.citedreference | Balter J, Yue C, Wang H, et al. Optimizing MRI for radiation oncology: initial investigations. MAGNETOM Flash. 2013: 45. | |
dc.identifier.citedreference | Schindel J, Zhang W, Bhatia SK, Sun W, Kim Y. Dosimetric impacts of applicator displacements and applicator reconstruction‐uncertainties on 3D image‐guided brachytherapy for cervical cancer. J Contemp Brachytherapy. 2013; 5 ( 4 ): 250 – 57. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.